Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N‐terminal pro B‐type natriuretic peptide levels

BACKGROUND: Widespread use of angiotensin receptor blocker and neprilysin inhibitor (ARNI) remains low, and many patients are unable to tolerate the medication due to hypotension at the currently recommended starting dose. HYPOTHESIS: The aim of this study is to assess if lower than standard doses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Amitabh C., Jer, Derek, Kuo, Ruth S., Yoo, David H., Christophy, Antonio, Mohan, Rajeev C., Srivastava, Ajay V., Heywood, James Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803354/
https://www.ncbi.nlm.nih.gov/pubmed/33277928
http://dx.doi.org/10.1002/clc.23509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803354/
https://www.ncbi.nlm.nih.gov/pubmed/33277928
http://dx.doi.org/10.1002/clc.23509

Ejemplares similares